Cannabidiol for People at Risk for Alzheimer's Disease
Cannabidiol for Individuals at Risk for Alzheimer's Disease: A Randomized Placebo Controlled Trial
This research explores if cannabidiol (CBD) can help protect the brain health of older adults who are at a higher chance of developing Alzheimer's disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-11142592 on NIH RePORTER |
What this research studies
Many older adults are already using CBD products, hoping they might help with pain, sleep, or even brain health. This project aims to understand if CBD can truly impact the progression of memory decline and dementia in people at risk for Alzheimer's. We will compare different forms of CBD against a placebo to see if it offers any protective benefits for cognitive health. This will be a carefully designed study to get clear answers about CBD's effects.
Who could benefit from this research
Good fit: Ideal candidates are older adults, aged 65 and above, who are at a high risk for developing Alzheimer's disease.
Not a fit: Patients not at risk for Alzheimer's disease or those under 65 years of age may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this research could offer a new way to help protect the cognitive health of older adults at risk for Alzheimer's disease.
How similar studies have performed: While preclinical data suggests CBD may have neuroprotective effects, this specific approach of a randomized controlled trial for Alzheimer's risk in humans is a novel and important step.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Hutchison, Kent E. — University of Colorado Denver
- Study coordinator: Hutchison, Kent E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.